Table 3.
A suggested template for cytological reporting of lymph node aspirate obtained using endobronchial ultrasound-guided transbronchial needle aspirate
| Name Patient ID |
Age Date of procedure |
Gender Provisional clinical diagnosis |
|---|---|---|
| Cytology report | ||
| Adequate | ||
| For reporting | ||
| Germinal center | Yes/No | |
| at least 100 lymphocytes per field at×100 magnification | Yes/No | |
| <2 groups of contaminating bronchial cells per field | Yes/No | |
| For molecular testing | ||
| >100 tumor cells | Yes/No | |
| Proportion of tumor cells ≥20% | Yes/No | |
| Inadequate | ||
| Diagnostic category | ||
| Diagnostic | ||
| Granulomatous inflammation (with or without necrosis) | ||
| Atypical | ||
| Suspicious of malignancy | ||
| Malignancy (small cell cancer, adenocarcinoma, squamous cell carcinoma or others) | ||
| Others (specify) | ||
| Nondiagnostic | ||
| Ancillary methods used | Report | |
| Cell block | ||
| LBC | ||
| Immunocytochemistry | ||
| Flow cytometry | ||
| FISH | ||
| Special stains | ||
| Others (cell scraping) | ||
| Molecular testing used | ||
| Descriptive report | ||
| Final diagnosis |